RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on ...
Many people deliberately chart different career paths from their parents, but not siblings Dana and Jack Larsen. Working with ...
Investing gives you the opportunity to grow your money, to help you get the most out of life, whatever goals you have in mind ...
RBC Capital analysts reaffirmed their Outperform rating on the stock in a note Tuesday, emphasizing that President Trump's recent executive order on wind leasing and permitting is unlikely to have a ...
RBC Capital Markets adjusted its stance on CF Industries Holdings Inc. (NYSE:CF), downgrading the stock from 'Outperform' to ...
RBC Capital analyst Gerard Cassidy maintained a Buy rating on Regions Financial (RF – Research Report) on January 17 and set a price target of ...
In a report released on January 15, Nik Modi from RBC Capital maintained a Buy rating on The Estée Lauder Companies (EL – Research Report), ...
The exodus of former First Republic advisors from JPMorgan continued this week. Raymond James and LPL Financial also made ...
Find insight on Orsted, Repsol, Equinor and more in the latest Market Talks covering energy and utilities.
RBC Bearings RBC +1.20% Get Free Report has outperformed the market over the past 15 years by 6.93% on an annualized basis ...
The group joining RBC's New York City office, led by advisors formerly affiliated with First Republic, gives it an additional ...